Cytokinetics regains compliance with Nasdaq rules – Businessweek
|
Cytokinetics regains compliance with Nasdaq rules
Businessweek The Nasdaq Stock Market sent the company a warning letter in June saying its shares could be taken off the index because of their low price. Cytokinetics transferred its listing to the Nasdaq Capital Market in December. It had until June to regain … Cytokinetics (CYTK) Regains Nasdaq Listing Compliance |
